Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials
暂无分享,去创建一个
[1] F. Norris,et al. The administration of guanidine in amyotrophic lateral sclerosis , 1974, Neurology.
[2] S H Appel,et al. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.
[3] C. Marsden,et al. Recent Developments in Parkinson's Disease , 1986 .
[4] D. Karnofsky. The clinical evaluation of chemotherapeutic agents in cancer , 1949 .
[5] M. Sanjak,et al. Natural history of amyotrophic lateral sclerosis. Quantification of symptoms, signs, strength, and function. , 1995, Advances in neurology.
[6] P. Andres,et al. The natural history of motoneuron loss in amyotrophic lateral sclerosis , 1988, Neurology.
[7] R. Sufit,et al. Design of clinical therapeutic trials in amyotrophic lateral sclerosis. , 1991, Advances in neurology.
[8] K. Yorkston,et al. Amyotrophic lateral sclerosis severity scale. , 1989, Neuroepidemiology.
[9] S. Fahn. Unified Parkinson's Disease Rating Scale , 1987 .
[10] J. Turner. Third Symposium on Parkinson's Disease , 1970 .
[11] L. L. Thurstone,et al. A method of scaling psychological and educational tests. , 1925 .
[12] G. Smith,et al. A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.
[13] Colin M. MacLeod,et al. Evaluation of chemotherapeutic agents , 1949 .